DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bnh5t4/special_report) has announced the addition of Decision Resources, Inc's new report "Special Report; 2011 Chartbook of International Pharmaceutical Prices" to their offering.
Payers in all countries are increasing their pressure on manufacturers to cut prices, but prescription drug pricing and reimbursement policies vary markedly among the leading pharmaceutical markets. To best determine pricing, pharmaceutical companies need to be aware of international price differentials. Many studies have compared retail prices in different countries, but international comparisons of pharmaceutical prices at the ex-manufacturer level are relatively uncommon. This chart book, our eighth annual analysis of international drug prices fills that need by comparing the prices of 200 of the world's best-selling branded drugs across 13 therapeutic areas and categories in seven countries. The report features 40 data-rich tables and figures that provide price comparisons in seven major markets and by select therapeutic area
Key Topics Covered:
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Overview
- Overall Price Differentials Among Markets
- Pricing Hierarchy in Individual Markets
- Price Variations by Therapeutic Area
- Cardiovascular Drugs
- Metabolic Disease Therapies
- Immune and Inflammatory Disease Therapies
- Infectious Disease Therapies
- Neurology Drugs
- Psychiatric Drugs
- Antineoplastic Drugs
- Treatments for the Side Effects of Chemotherapy
- Gastrointestinal Drugs
- Genitourinary Drugs
- Pain Therapies
- Vaccines
- Miscellaneous Other Drugs
- Prices of Biologics
- Outlook and Implications for the Pharmaceutical Industry
- Appendix - Tables
For more information visit http://www.researchandmarkets.com/research/bnh5t4/special_report
Source: Decision Resources, Inc